Novo Nordisk has agreed to acquire Inversago for up to $1.075 billion in cash if certain development and commercial milestones are achieved....Inversago is targeting metabolic and fibrosis related diseases! (All the "expert" analysts and commentators will catch up in a few weeks)
https://www.biopharminternational.com/view/novo-nordisk-to-acquire-inversago-pharma
Movement at the station!
Add VBS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.895M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 11320 | 1 |
View Market Depth
| Last trade - 11.12am 19/06/2024 (20 minute delay) ? |
| VBS (ASX) Chart |
Day chart unavailable